Myopia Action Month concludes its last week with an uplifting international discussion hosted by CooperVision, who is a Premier sponsor. The conversation poses a series of thought-provoking questions to six ECPs, educators, and researchers regarding their personal journeys and experiences in myopia control and management.

The online video will be released on Tuesday, September 26 at 10:00 am GMT, as part of Myopia Profile’s comprehensive collection of free online seminars and educational resources that have been offered throughout the month.

“Myopia Action Month has provided an exceptional platform for the eye care community worldwide to unite and address the critical issue of childhood myopia,” said Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “This exclusive discussion zeros in on key aspects of the myopia control and management journey, aiming to inspire anyone looking to take the next step on their own path. As a global leader in the field, it’s a privilege to partner on initiatives like this inaugural event.”

The conversations center on the theme of “the one thing” that has helped define those journeys. The resulting story examines the core motivations that led the diverse group of participants to begin taking action, standout moments that have defined their experiences, and visions for the next five years.

Contributors include:

• Andy Britton, Specialist Optometrist and Director, Specsavers, United Kingdom
• Li Lian Foo, Clinical Assistant Professor, Duke-NUS Graduate Medical School Consultant Ophthalmologist, Singapore National Eye Centre, Singapore
• Aamena Kazmi, OD, ABO Diplomate, United States
• Jamesina Lowe, OD, Canada
• Elena Garcia Rubio, Co-Director of the National Institute of Vision, Spain
• Celine Zhang, OD, V Vis Sci/B Optom(Hons), SpecCert MMP(Optom), UniMelb Eyecare Plus, Australia

From left to right: Jamesina Lowe, OD, Canada; Aamena Kazmi, OD, ABO Diplomate, United States; Elena Garcia Rubio, Co-Director of the National Institute of Vision, Spain; Li Lian Foo, Clinical Assistant Professor, Duke-NUS Graduate Medical School Consultant Ophthalmologist, Singapore National Eye Centre, Singapore; Andy Britton, Specialist Optometrist and Director, Specsavers, United Kingdom; Celine Zhang, OD, V Vis Sci/B Optom(Hons), SpecCert MMP(Optom), UniMelb Eyecare Plus, Australia

“Participating in Myopia Action Month allowed me to contemplate my personal journey with myopia management,” said Dr. Kazmi. “Sharing these experiences holds great significance as it helps introduce more children to myopia control, which aligns perfectly with this month’s initiative.”

For more information on Myopia Action Month and to watch CooperVision’s international video, visit www.myopiaaction.com.

Click HERE for the full press release.

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology^™ (DOT 0.2) spectacle lenses. The lenses use thousands of light scattering elements called dots, designed to mimic more natural contrast on the retina—a unique mechanism of action to slow myopia progression in children.

The in-depth paper explains the relationship between artificially high contrast signals at the retina and myopia progression. This groundbreaking research led to the development of DOT to manage such contrast, now clinically proven via the pivotal CYPRESS study to slow myopia progression in children from age six. Its efficacy is particularly of note for the youngest patients, who would typically experience the fastest progression.

Read the white paper online or downloaded as a PDF.

“Harnessing the power of contrast management is a revolutionary approach to controlling myopia. Our DOT spectacle lenses are now paving a new path to reducing myopia progression from an early age. This white paper goes deeper into the science to explain the mechanisms of action, helping eye care professionals better understand the innovation,” said SightGlass Vision Vice President of Clinical, Medical & Professional Affairs Marcella McParland.

“As a more recent entrant into the myopia management field, our Diffusion Optics Technology paper will help disseminate the substantial science behind contrast management and its application. DOT spectacle lenses present a compelling alternative to existing solutions for slowing myopia’s progression in children,” added Andrew Sedgwick, SightGlass Vision’s CEO.

Click HERE for the full press release.

Read more related articles from Optik NOW HERE.